SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-043010
Filing Date
2019-11-12
Accepted
2019-11-12 17:01:53
Documents
78
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-10q_20190930.htm 10-Q 2117544
2 EX-31.1 itrm-ex311_8.htm EX-31.1 17596
3 EX-31.2 itrm-ex312_9.htm EX-31.2 17904
4 EX-32.1 itrm-ex321_7.htm EX-32.1 10672
5 EX-32.2 itrm-ex322_6.htm EX-32.2 10549
  Complete submission text file 0001564590-19-043010.txt   7679506

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT itrm-20190930.xml EX-101.INS 1681051
7 XBRL TAXONOMY EXTENSION SCHEMA itrm-20190930.xsd EX-101.SCH 54783
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itrm-20190930_cal.xml EX-101.CAL 58916
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itrm-20190930_def.xml EX-101.DEF 195155
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE itrm-20190930_lab.xml EX-101.LAB 433440
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itrm-20190930_pre.xml EX-101.PRE 346141
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 191210595
SIC: 2834 Pharmaceutical Preparations